# TSPYL5

## Overview
TSPYL5 (testis-specific protein, Y-encoded-like 5) is a gene that encodes a multifunctional protein involved in various cellular processes, including chromatin remodeling, transcriptional regulation, and cell cycle progression. The TSPYL5 protein is characterized by a high proportion of intrinsically disordered regions and contains a nucleosome assembly protein (NAP)-like domain, which facilitates its role as a histone chaperone. This protein is involved in the regulation of gene expression, particularly influencing the expression of the CYP19A1 gene, and plays a significant role in endothelial cell function and pluripotency maintenance in human pluripotent stem cells. TSPYL5 interacts with several proteins, including ubiquitin-specific protease 7 (USP7) and DEAD-box RNA helicases, implicating it in processes such as RNA metabolism and the modulation of p53 stability. Clinically, TSPYL5 is associated with various cancers, where it can act as either an oncogene or a tumor suppressor, depending on the context, making it a potential target for therapeutic intervention (Silonov2023Insights; Na2018TSPYL5mediated; Weissbein2017Cultureinduced).

## Structure
The TSPYL5 protein is characterized by a significant proportion of intrinsically disordered regions (IDRs), accounting for 65.7% of its structure, which contributes to its potential role in liquid-liquid phase separation (LLPS) (Silonov2023Insights). The protein contains a nucleosome assembly protein (NAP)-like domain spanning amino acids 198-382, which is crucial for its function as a histone chaperone, facilitating histone H3/H4 deposition and nucleosome assembly (Silonov2023Insights). This domain is involved in chromatin remodeling and transcriptional regulation (Silonov2023Insights).

TSPYL5 has two nuclear localization signal (NLS) sites, one with a high probability in the 4-27 amino acid region and another with a lower probability in the 132-148 amino acid region, which mediate its nuclear localization (Silonov2023Insights). The protein also contains two DNA-binding sites (6-22 aa, 121-131 aa) and one RNA-binding site (12-19 aa) (Silonov2023Insights). Post-translational modifications include two O-linked glycan sites at T409 and S414, suggesting a role in dynamic protein cycling (Silonov2023Insights).

The TSPYL5 protein is involved in interactions with histones, RNA helicases, and ribosomal proteins, highlighting its potential roles in various cellular processes (Silonov2023Insights).

## Function
TSPYL5 (TSPY-like 5) is a gene that encodes a protein involved in various cellular processes, including the regulation of gene expression and cell cycle progression. In healthy human cells, TSPYL5 plays a significant role in modulating the expression of the CYP19A1 gene, which is crucial for aromatase expression. This regulation occurs through TSPYL5's binding to a specific promoter region of CYP19A1, influencing estradiol synthesis, particularly in adipose tissue (Liu2013TSPYL5).

TSPYL5 is also involved in enhancing the function of human endothelial cells (ECs). It promotes EC proliferation, migration, and tube formation, while providing protection against apoptosis. This is achieved through the inhibition of the p53 protein, a key regulator of the cell cycle and apoptosis. TSPYL5 interacts with ubiquitin-specific protease 7 (USP7) to modulate p53 stability, thereby influencing EC functions and promoting angiogenesis (Na2018TSPYL5mediated).

In the context of human pluripotent stem cells (hPSCs), TSPYL5 is actively expressed in early-stage human embryonic stem cells and is crucial for maintaining pluripotency. Its expression decreases during prolonged culturing due to hypermethylation, which affects cell growth regulation and survival (Weissbein2017Cultureinduced).

## Clinical Significance
TSPYL5 is implicated in various cancers, including breast, lung, prostate, and colorectal cancers. In breast cancer, TSPYL5 is frequently amplified and associated with poor prognosis by promoting the degradation of the tumor suppressor p53 through inhibition of ubiquitin-specific peptidase 7 (USP7) (Silonov2023Insights). In lung cancer, TSPYL5 expression is linked to resistance to chemotherapy drugs like cisplatin and gemcitabine, as well as resistance to γ-irradiation via the PTEN/AKT signaling pathway (Silonov2023Insights; Kim2010TSPYL5). 

In prostate cancer, TSPYL5 expression is inversely related to DNA methylation, leading to its silencing in advanced tumors. This silencing is associated with reduced sensitivity to chemotherapy drugs such as docetaxel and paclitaxel (Kumar2017Testis). TSPYL5 expression is lower in high-grade prostate tumors, potentially serving as an indicator of advanced disease (Kumar2017Testis). 

In colorectal cancer, TSPYL5 expression is downregulated, suggesting its role as a tumor suppressor. Overexpression of TSPYL5 in colorectal cancer cell lines suppresses cell proliferation and promotes apoptosis, potentially through the activation of endoplasmic reticulum stress (Huang2020TSPYL5). 

These findings highlight TSPYL5's potential as a therapeutic target and biomarker in various oncological diseases.

## Interactions
TSPYL5 is involved in various protein interactions that influence cellular processes. It interacts with histone H3/H4 through its nucleosome assembly protein (NAP)-like domain, playing a role in chromatin remodeling and transcriptional regulation (Silonov2023Insights). TSPYL5 also interacts with ubiquitin-specific peptidase 7 (USP7), inhibiting its function and promoting the degradation of the tumor suppressor p53, which is significant in cancer cell drug resistance (Silonov2023Insights; Na2018TSPYL5mediated). 

The protein is characterized by a high proportion of intrinsically disordered regions, which facilitate its interactions with various partners, including RNA helicases and ribosomal proteins, suggesting a role in RNA metabolism and cytoplasmic translation (Silonov2023Insights). TSPYL5's interaction with DEAD-box RNA helicases such as DDX6, DDX21, and DDX24 further implicates it in RNA processes like translation inhibition and mRNA degradation (Silonov2023Insights).

TSPYL5 also forms a complex with TSPY1, enhancing the degradation of p53 through the 26S proteasome system, which affects cell proliferation and apoptosis (Shen2018TSPY1). These interactions highlight TSPYL5's multifaceted role in cellular regulation and its potential as a therapeutic target.


## References


[1. (Kim2010TSPYL5) Eun Jin Kim, So Yong Lee, Tae Rim Kim, Soo Im Choi, Eun Wie Cho, Kug Chan Kim, and In Gyu Kim. Tspyl5 is involved in cell growth and the resistance to radiation in a549 cells via the regulation of p21waf1/cip1 and pten/akt pathway. Biochemical and Biophysical Research Communications, 392(3):448–453, February 2010. URL: http://dx.doi.org/10.1016/j.bbrc.2010.01.045, doi:10.1016/j.bbrc.2010.01.045. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2010.01.045)

[2. (Liu2013TSPYL5) Mohan Liu, James N. Ingle, Brooke L. Fridley, Aman U. Buzdar, Mark E. Robson, Michiaki Kubo, Liewei Wang, Anthony Batzler, Gregory D. Jenkins, Tracy L. Pietrzak, Erin E. Carlson, Matthew P. Goetz, Donald W. Northfelt, Edith A. Perez, Clark V. Williard, Daniel J. Schaid, Yusuke Nakamura, and Richard M. Weinshilboum. Tspyl5 snps: association with plasma estradiol concentrations and aromatase expression. Molecular Endocrinology, 27(4):657–670, April 2013. URL: http://dx.doi.org/10.1210/me.2012-1397, doi:10.1210/me.2012-1397. This article has 47 citations.](https://doi.org/10.1210/me.2012-1397)

[3. (Shen2018TSPY1) Ying Shen, Wenling Tu, Yunqiang Liu, Xiling Yang, Qiang Dong, Bo Yang, Jinyan Xu, Yuanlong Yan, Xue Pei, Mohan Liu, Wenming Xu, and Yuan Yang. Tspy1 suppresses usp7-mediated p53 function and promotes spermatogonial proliferation. Cell Death &amp; Disease, May 2018. URL: http://dx.doi.org/10.1038/s41419-018-0589-7, doi:10.1038/s41419-018-0589-7. This article has 20 citations.](https://doi.org/10.1038/s41419-018-0589-7)

[4. (Weissbein2017Cultureinduced) Uri Weissbein, Omer Plotnik, Dan Vershkov, and Nissim Benvenisty. Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells. PLOS Genetics, 13(8):e1006979, August 2017. URL: http://dx.doi.org/10.1371/journal.pgen.1006979, doi:10.1371/journal.pgen.1006979. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1006979)

[5. (Huang2020TSPYL5) Chao Huang, Chunping He, Peng Ruan, and Rui Zhou. Tspyl5 activates endoplasmic reticulum stress to inhibit cell proliferation, migration and invasion in colorectal cancer. Oncology Reports, 44(2):449–456, June 2020. URL: http://dx.doi.org/10.3892/or.2020.7639, doi:10.3892/or.2020.7639. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2020.7639)

[6. (Silonov2023Insights) Sergey A. Silonov, Eugene Y. Smirnov, Eva A. Shmidt, Irina M. Kuznetsova, Konstantin K. Turoverov, and Alexander V. Fonin. Insights into the cellular localization and functional properties of tspyl5 protein. International Journal of Molecular Sciences, 25(1):39, December 2023. URL: http://dx.doi.org/10.3390/ijms25010039, doi:10.3390/ijms25010039. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25010039)

[7. (Kumar2017Testis) Senthil R. Kumar, Jeffrey N. Bryan, Magda Esebua, James Amos-Landgraf, and Tanner J. May. Testis specific y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma. BMC Cancer, February 2017. URL: http://dx.doi.org/10.1186/s12885-017-3134-7, doi:10.1186/s12885-017-3134-7. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-017-3134-7)

[8. (Na2018TSPYL5mediated) Hee-Jun Na, Chung Eun Yeum, Han-Seop Kim, Jungwoon Lee, Jae Yun Kim, and Yee Sook Cho. Tspyl5-mediated inhibition of p53 promotes human endothelial cell function. Angiogenesis, 22(2):281–293, November 2018. URL: http://dx.doi.org/10.1007/s10456-018-9656-z, doi:10.1007/s10456-018-9656-z. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10456-018-9656-z)